Vaccines

Moderna Inc (NASDAQ: MRNA) Chief Medical Officer Tal Zaks said that the drugmaker’s COVID-19 vaccine would be available for children by mid-2021, Axios reported Monday. What Happened: Zaks told Axios On HBO in an interview that he hopes that the vaccine for children would be available by...

AstraZeneca Plc (NYSE: AZN) and Oxford University’s COVID-19 vaccine prevented 70% of the inoculated trial participants from developing COVID-19, early analysis of trial data indicates. What Happened: The results were based on data gathered from two different dosing regimens. One dosing...

Microsoft Corporation (NASDAQ: MSFT) co-founder Bill Gates expressed optimism on the efficacy of COVID-19 vaccines made by various drugmakers in an interview with CNN on Sunday. What Happened: The billionaire told CNN’s Fareed Zakaria that while vaccines from Pfizer Inc (NYSE: PFE) and...

Pfizer Inc (NYSE: PFE) is likely to file an application with the United States Food and Drug Administration for emergency use of its COVID-19 vaccine on Friday, with Moderna Inc (NASDAQ: MRNA) to do the same shortly after. What Happened: The disclosure on Pfizer’s COVID-19 vaccine was made by...

A hundred million doses of AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine would be ready for distribution in India by December and an inoculation drive could begin the same month, Bloomberg reported Friday. What Happened: Adar Poonawalla, CEO of  Serum Institute of India Ltd — a...

Pfizer Inc (NYSE: PFE) is in negotiations with the government of Brazil to supply its COVID-19 vaccine to the country, Reuters reported Thursday. What Happened: The negotiations are reportedly centered around supplying the vaccine in the first quarter of 2021. “We are working strongly with...

AstraZeneca plc (NYSE: AZN) has received the regulatory nod to conduct clinical trials of its COVID-19 vaccine in Chile and Peru, Reuters reported Wednesday. What Happened: Chile’s President Sebastian Pinera said that his nation’s health regulator had approved the British company...

Senior sources in the British government expect a verdict on Pfizer Inc's (NYSE: PFE) COVID-19 vaccine results, before AstraZeneca Plc's (NASDAQ: AZN) trials, according to a report from the Sunday Times. What Happened: Pfizer's vaccine is being...

Data from AstraZeneca plc's (NASDAQ: AZN) COVID-19 vaccine trial, developed in collaboration with the University of Oxford, has shown encouraging signs for the elderly, the Financial Times reports. Researchers found that the vaccine triggers protective antibodies and T-cells...

The U.S. Food and Drug Administration (FDA) has completed a review of adverse events observed in participants of AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine clinical trial, according to Reuters. What Happened: The U.S. trial of the British company's vaccine candidate...

U.S. President Donald Trump appeared on Fox Business with Stuart Varney for an hour Thursday morning to share his thoughts on several topics. Congress continues to be at a stalemate over a potential stimulus offer. Trump said he would raise the stimulus offer above $1.8 trillion. Trump said he...

The World Bank said Monday that its Board of Executive Directors has approved $12 billion in financing for developing countries to purchase and distribute COVID-19 vaccines, tests, and treatments. What Happened: The sum will support the vaccination of up to one billion people and constitutes a...

Johnson & Johnson’s (NYSE: JNJ) COVID-19 vaccine trial has been paused over a participant developing an unexplained illness, Stat reported late Monday. The company later confirmed the move in a statement. What Happened: The pharmaceutical company reportedly told the researchers conducting...

The COVID-19 vaccine initiative known as COVAX got a boost Friday (Beijing time) when the Chinese foreign ministry announced that the country had officially joined the facility, Reuters reported. What Happened: China is pledging support to the vaccine initiative which is focussed on low and middle-...

British drugmaker AstraZeneca PLC (NYSE: AZN) has pledged that it will not profit from its under-development COVID-19 vaccine until the pandemic is over. According to the Financial Times, that timeline may be a lot shorter than most people anticipated. What Happened: The United Kingdom-based...